Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) Share Price

Company Profile

Business description
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalosporins, and bone resorption inhibitors. Its products mainly focus on the areas of cardio-cerebral vascular disease, diabetes, complications, anti-tumor, and orthopedics. Its business lines include high-end chemical drugs, biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other countries and regions.
Contact
No. 6009, Shennan Avenue
37th Floor, Main Building, Tower B
Chegongmiao Greenview Plaza
Futian District
Shenzhen518040
CHN
T: +86 75583867888
https://www.salubris.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
3,596

Recommended

These three companies are trading at a significant premium to our fair value.

Morningstar | 08 September 2025

Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.

Malik Ahmed Khan, CFA | 05 September 2025

A difficult year but better times ahead.

Johannes Faul, CFA | 05 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,126.90	2.50	-0.03%
CAC 40	7,720.44	21.52	0.28%
DAX 40	23,702.04	105.06	0.45%
Dow JONES (US)	45,316.53	304.76	-0.67%
FTSE 100	9,227.04	18.83	0.20%
HKSE	25,633.91	215.93	0.85%
NASDAQ	21,700.39	7.30	-0.03%
Nikkei 225	43,643.81	625.06	1.45%
NZX 50 Index	13,281.14	57.61	0.44%
S&P 500	6,464.58	16.92	-0.26%
S&P/ASX 200	8,849.60	5.60	-0.06%
SSE Composite Index	3,826.84	14.33	0.38%